Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?

To determine differences in prognosis between primary progressive Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL), we retrospectively analyzed patients with progressive lymphoma who were treated with different salvage chemotherapy regimens including high-dose chemotherap...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2000-01, Vol.18 (2), p.332-339
Hauptverfasser:	JOSTING, A, REISER, M, RUEFFER, U, SALZBERGER, B, DIEHL, V, ENGERT, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Disease Progression Dose-Response Relationship, Drug Female Hematopoietic Stem Cell Transplantation Hodgkin Disease - drug therapy Hodgkin Disease - pathology Hodgkin Disease - therapy Humans Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - therapy Male Medical sciences Middle Aged Pharmacology. Drug treatments Prognosis Retrospective Studies Salvage Therapy Severity of Illness Index Survival Analysis Transplantation, Autologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!